Cochlear | COH - Sales Revenues


Cochlear reported AUD1.18B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Fisher Paykel Healthcare NZD 1.24B 137.8M Jun/2026
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 86.5M 125.57M Jun/2026
Mesoblast USD 63.9M 33.6M Jun/2026
Monash IVF AUD 137.86M 72.09M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
Regis Healthcare AUD 667.75M 70.63M Dec/2025
ResMed USD 1.43B 8.6M Mar/2026
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.42B 30M Jun/2026
Telix Pharmaceuticals AUD 477.35M 63.92M Jun/2026